Detection of Genetic Markers of Lung Cancer
Public ClinicalTrials.gov record NCT00280202. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Detection of Genetic Markers of Lung Cancer Initiation and Progression
Study identification
- NCT ID
- NCT00280202
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- University of Pittsburgh
- Other
- Enrollment
- 6,000 participants
Conditions and interventions
Conditions
Interventions
- Analysis of lymph nodes Procedure
- Biopsy of abnormal & suspicious areas of the bronchial tree Procedure
- Biopsy of the major carinal area Procedure
- Bronchoalveolar Lavage (BAL) for cytokine analysis Procedure
- Correlation of flow cytometric & RT PCR for TNM stage Procedure
- Evaluation of the tumor for DNA mutations Procedure
Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 1996
- Primary completion
- Nov 30, 2050
- Completion
- Nov 30, 2050
- Last update posted
- Oct 23, 2025
1996 – 2050
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00280202, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 23, 2025 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00280202 live on ClinicalTrials.gov.